Langer, Harald F.

Complement-mediated inhibition of neovascularization reveals a point of convergence between innate immunity and angiogenesis

Langer, H. F., Chung, K.-J., Orlova, V. V., Choi, E. Y., Kaul, S., Kruhlak, M. J., Alatsatianos, M., DeAngelis, R. A., Roche, P. A., Magotti, P., et al. (2010) · Blood

Complement system in diseasesAngiogenesis and VEGF in Cancer

Cited by 176

Differential retrotranslocation of mitochondrial Bax and Bak

Todt, F., Cakir, Z., Reichenbach, F., Emschermann, F., Lauterwasser, J., Kaiser, A., Ichim, G., Tait, S. W., Frank, S., Langer, H. F., et al. (2015) · The EMBO Journal

Cell death mechanisms and regulationMitochondrial Function and Pathology

Cited by 172

VEGF-B prevents excessive angiogenesis by inhibiting FGF2/FGFR1 pathway

Lee, C., Chen, R., Sun, G., Liu, X., Lin, X., He, C., Xing, L., Liu, L., Jensen, L. D., Kumar, A., et al. (2023) · Signal Transduction and Targeted Therapy

Angiogenesis and VEGF in CancerFibroblast Growth Factor Research

Cited by 72

Myocardial Expression of the Anaphylatoxin Receptor C3aR is Associated with Cardiac Inflammation and Prognosis in Patients with Non-Ischaemic Heart Failure

Mueller, K. A. L., Patzelt, J., Sauter, M., Maier, P., Gekeler, S., Klingel, K., Kandolf, R., Seizer, P., Gawaz, M., Geisler, T., et al. (2018) · ESC Heart Failure

Cardiac Fibrosis and RemodelingViral Infections and Immunology Research

Cited by 12